Cepheid Danaher Q4 Revenues Rise 3 Percent Despite Difficulties in China The firm's Life Sciences segment saw 8 percent growth year over year, while the Diagnostics sector rose 3 percent in the quarter. New Products Posted to GenomeWeb: Foundation Medicine, Cepheid, Thermo Fisher, Olink, More New products and services posted to GenomeWeb for the week of Nov. 14, 2022 Cepheid Nabs CE Mark for Group B Strep Test The PCR-based Xpert Xpress GBS test can help screen pregnant women for Streptococcus infections that can lead to early-onset neonatal sepsis. Danaher Q3 Revenues Rise 6 Percent as Businesses Step Back From COVID-19 Products Life sciences revenues were up 4 percent, diagnostics revenues grew 10 percent, and environmental and applied solutions revenues increased 5 percent. Highly Anticipated Cepheid Omni Point-of-Care System Falls Off Radar Premium A wall of silence surrounds the fate of the point-of-care diagnostics instrument, and the company will neither confirm nor deny whether Omni has been shelved. Jul 21, 2022 Danaher Cites Diversified Business, Core Growth, Sustained China Sales as Drivers of Strong Q2 Premium Jun 27, 2022 Cepheid, BioGX to Jointly Develop Monkeypox PCR Test for GeneXpert System May 19, 2022 Cepheid Gets CE Mark for Updated Rapid COVID MDx Test May 12, 2022 Cepheid Adds New Gene Target to SARS-CoV-2 Molecular Test to Account for Variants May 2, 2022 Top Five Articles on GenomeWeb Last Week: Illumina, Janssen Biotech, Cepheid, More Apr 25, 2022 Cepheid Developing Xpert Test to Distinguish Between Bacterial, Viral Infections Premium Jan 27, 2022 Danaher Q4 Revenues Rise 21 Percent Jan 14, 2022 In Brief This Week: BGI, Gencove, Cepheid, Biocartis, Biognosys, Co-Diagnostics, More Oct 21, 2021 Cepheid Sees High Demand for Respiratory Tests Through Remainder of 2021 Premium Oct 14, 2021 Cepheid Obtains CE Mark for Expanded Combo COVID Test Sep 14, 2021 Updated Cepheid SARS-CoV-2, Flu, RSV Test Nabs FDA EUA Jul 30, 2021 Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests Jul 29, 2021 Cepheid Nabs CE Mark for PCR-Based HIV-1 Tests Apr 29, 2021 Pandemic Pushes Handheld qPCR Devices Closer to Commercialization Premium Apr 22, 2021 Demand for Cepheid SARS-CoV-2 Point-of-Care Tests Expected to Continue Through 2022 Premium Apr 22, 2021 Danaher Q1 Revenues Up 58 Percent Apr 13, 2021 Danaher Expects Q1 2021 Revenue Growth Above Previous Guidance Mar 31, 2021 FDA Posts Info on Impact of SARS-CoV-2 Mutations on Test Effectiveness Feb 18, 2021 WHO Finds High Diagnostic Accuracy in Three Classes of MDx Technologies for TB Testing, Resistance Jan 28, 2021 Danaher Q4 Revenues up 39 Percent Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.